The PI3K/Akt pathway mediating FOXO1 binding to the promoter of MALAT1 could be a mechanism for MALAT1 inducing EMT and reducing trastuzumab sensitivity in HER2+ breast cancer. The gene discussed is MALAT1; the disease is breast cancer.